Skip to main content
. Author manuscript; available in PMC: 2013 Apr 23.
Published in final edited form as: J Clin Exp Neuropsychol. 2011 Jun 24;33(7):735–752. doi: 10.1080/13803395.2011.553584

TABLE 2.

Substance use characteristics of sample

MJ−/HIV− (n = 21)
MJ+/HIV− (n = 23)
MJ−/HIV+ (n = 25)
MJ+/HIV+ (n = 17)
M (SD) % Mdn [IQR] M (SD) % Mdn [IQR] M (SD) % Mdn [IQR] M (SD) % Mdn [IQR]
Years of cocaine and/or heroin use 20.8 (5.2) 23.7 (9.0) 21.0 (8.4) 22.9 (9.7)
Days since last use of cocaine and/or heroin 229 [120, 1, 486] 210 [90, 365] 300 [135, 714] 350 [187, 627]
Days since last marijuana use 2, 532 [158, 6, 844] 2, 980 [240, 7, 200] 2, 523 [350, 8, 121] 365 [218, 2, 829]
History of lifetime SCID-SAM dependence
 Alcohol 86 83 84 88
 Cocaine 91 96 96 100
 Heroin 52 74 44 59
 Stimulants 0 9 12 24
KMSK peak
 Alcohol 11 [8, 12] 10 [8, 12] 11 [9, 12] 10 [7, 12]
 Cocaine 13 [11, 16] 13 [11, 16] 15 [13, 15] 15 [12, 15]
 Heroin 2 [0, 11] 9 [2, 11] 2 [0, 12] 8 [0, 12]
 Marijuana* 7 [4, 12] 12 [9, 15] 6 [2, 11] 13 [11, 15]

Note. Mdn, median; IQR, interquartile range; MJ, marijuana; SCID-SAM, Structured Clinical Interview for DSM–IV–Substance Abuse Module; DSM–IV, Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition; KMSK, Kreek–McHugh–Schluger–Kellogg Scale.

*

p < .05; MJ+/HIV−, MJ+/HIV+ > MJ−/HIV−, MJ−/HIV+.